Sarah Kathryn Rouan - Jun 30, 2021 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)

Role
Director
Signature
/s/ Jed A. Latkin for S. Kathryn Rouan, by power of attorney
Stock symbol
NAVB
Transactions as of
Jun 30, 2021
Transactions value $
$0
Form type
4
Date filed
7/7/2021, 05:46 PM
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $0 +4.89K +36.64% $0.00 18.2K Jun 30, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of quarterly non-employee director fees.